Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B

Carcinogenesis

Volumn 17, Issue 1, 1996, Pages 37-43

  Diwan, Bhalchandra A ^a   Henneman, John R ^a   Rice, Jerry M ^b   Nims, Raymond W ^b,c  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Microbiological Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; CYTOCHROME P450; DIETHYLNITROSAMINE; LIOTHYRONINE; PHENOBARBITAL; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DEALKYLATION; ENZYME ACTIVITY; ENZYME INDUCTION; LIOTHYRONINE BLOOD LEVEL; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID ADENOMA; THYROID CANCER; THYROID FOLLICLE CELL; THYROXINE BLOOD LEVEL; TUMOR PROMOTION; TUMOR VOLUME;

ANIMALS; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; DIETHYLNITROSAMINE; ENZYME INDUCTION; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PRECANCEROUS CONDITIONS; PYRIDINES; RATS; RATS, INBRED F344; THYROID HORMONES; THYROID NEOPLASMS; WEIGHT GAIN;

EID: 0029925068     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.1.37     Document Type: Article

References (24)

1. Poland,A., Mac,I., Glover,E., Boatman,R.J., Ebetino,F. and Kende,A.S. (1980) 1.4-bis[2-(3,5-Dichloropyridyloxy)]benzene. a potent phenobarbital-like inducer of microsomal monooxygenase activity. Mol. Pharmacol., 18, 571-580.
2. Diwan,B.A., Lubet,R.A., Ward,J.M., Hrabie,J.A. and RiceJ.M. (1992) Tumor-promoting and hepatocarcinogenic effects of 1.4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethy lamine. Carcinogeneus, 13, 1893-1901.
3. Poland,A., Mac,I. and Glover,E. (1981) Species differences in responsiveness to 1.4-bis[2-(3.5-dichloropyridyloxy)]benzene, a potent phenobarbital-like inducer of microsomal monooxyaenase activity. Mol. Pharmacol., 20. 442-450.
4. Nims,R.W., Sinclair,P.R., Sinclair,J.F, Dragnev,K.H., Jones,C.R., Mellini,D.W., Thomas.P.E. and Lubet,R.A. (1993) Dose-response relationships for the induction of P450 2B by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in rat and cultured rat hepatocytes. Xenobiotica, 23. 1411-1426.
5. Romano,M., Esteve,A., Masturzo,P., Galliani,G. and Salmona,M. (1986) Biochemical characterization of the hepatic effects in mice and rats of 1.4-bis[2-(3,5-dichloropyridyloxy)]benzene, a hepatic neoplasm promoter. Toxicol. Appl. Pharmacol., 83. 379-385.
6. Bastomsky,C.H., Murthy,P.V.N. and Banovac.K. (1976) Alterations in thyroxine metabolism produced by cutaneous application of microscope immersion oil: effects due to polychlorinated biphenyls. Endocrinology, 98. 1309-1314.
7. Hiasa,Y., Kitahori,Y., Ohshima.M., Fujita,T., Yuasa,T., Konishi,N. and Miyashiro.A. (1982) Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine. Carginogenesis, 3, 1187-1190.
8. McClain,R.M., Posch,R.C., Bosakowski,T. and Armstrong, J.M. (1988) Studies on the mode of action for thyroid gland tumor promotion in rats by phenobarbital. Toxicol Appl. Pharmacol., 94. 254-265.
9. Diwan,B.A., Rice,J.M., Nims,R.W., Lubet,R.A., Hu,H. and Ward,J.M. (1988) P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5.5-diethylhydantoin. analogs of the barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats. Cancer Res., 48, 2492-2497.
10. McClain,R.M., Levin,A.A., Posch,R. and Downing,J.C. (1989) The effect of phenobarbital on the metabolism and excretion of thyroxine in rats. Toxicol. Appl. Pharmacol., 99, 216-228.
11. Hill,R.N., Erdreich,L.S., Paynter.O.E., Roberts,P.A., Rosenthal,S.L. and Wilkinson,C.F. (1989) Thyroid follicular cell carcinogenesis. Fundam. Appl. Toxicol., 12. 629-697.
12. Campbell,H.A., Xu,Y.-D., Hanigan,M.H. and Pitot,H.C. (1986) Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver. J. Natl Cancer Inst., 76, 751-767.
13. Nims,R.W., Devor,D.E., Henneman,J.R. and Lubet,R.A. (1987) Induction of alkoxyresorufin O-dealkylases. epoxide hydrolase and liver weight gain: correlation with tumor promoting activity in a series of barbiturates. Carcinogenesis. 8. 67-71.
14. Lubet,R.A., Nims,R.W., Ward,J.M., Rice,J.M. and Diwan,B.A. (1989) Induction of thyroid P450 IIB1 and its relationship to liver tumor promotion. J. Am. Coll. Toxicol., 8, 253-262.
15. Böhlen,P., Stein.S., Dairman,W. and Udenfriend,S. (1973) Fluorimetric assay of proteins in the nanosram range. Archs Biochem. Biophys., 155, 213-220.
16. Kelly,M., Womack,J. and Safe.S. (1990) Effects of cytochrome P-450 monooxygenase inducers on mouse hepatic microsomal metabolism of testosterone and alkoxyresorufins. Biochem. Pharmacol., 39. 1991-2004.
17. Raunio,H., Kolo.R., Honkakoski.P. Jarvinen,P, Lang,M.A., Wahakangas. K., Gelboin,H.V., Park,S.S. and Pelkonen,O. (1988) Mouse hepatic cytochrome P-450 isozyme induction by TCPOBOP. pyrazole and phenobarbital. Biochem. Pharmacol., 37. 4141-4147.
18. Dragani,T.A., Manenit,G. and Della Porta,G. (1987) Genetic susceptibility to murine hepatocarcinogenesis is associated with high growth rate of NDEA-initiated hepatocytes. J. Cancer Res. Clin. Oncol. 113. 223-229.
19. Rice,J.M., Diwan.B.A., Hu,H., WardJ,M., Nims,R.W. and Lubet,R.A. (1994) Enhancement of hepatocarcinogenesis and induction of specific cytochrome P450-dependent monooxygenase activities by the barbiturates allobarbital, aprobarbital, pentobarbital, secobarbital. and 5-phenyl- and 5-ethylbarbituric acids. Carcinogenesis. 15, 395-402.
20. Wolf,G.L., Leakey,J.E.A., Bazare,J.J., Harmon,J.R., Webb,PJ. and Law,M.G. (1991) Susceptibility to phenobarbital promotion of hepatocarcinogenesis - correlation with differential expression and induction of hepatic drug metabolizing enzymes in heavy and light male (C3H VY)F1 hybrid mice. Carcinogenesis, 12, 911-915.
21. Chen,Z.Y. and Eaton,D.L. (1991) Differential regulation of cytochrome(s) P450 2B1 by phenobarbital in hepatic hyperplastic nodules induced by aflatoxin BI or diethylnitrosamine plus 2-acetylaminofluorene in male F344 rats. Toxicol. Appl, Pharmacol., 111, 132-144.
22. Schulte-Hermann,R., Roome,N., Timmermann-Trosiener,I. and Schuppler,J. (1984) Immunohistochemical demonstration of phenobarbitalinducible cytochrome P450 in putative preneoplastic foci of rat liver. Carcinogenesis. 7, 1651-1655.
23. Saito,K., Kaneko,H., Sato,K., Yoshitake,A. and Yamada,H. (1991) Hepatic UDP-glucuronyltransferase(s) activity toward thyroid hormones in rats: induction and effects on serum thyroid hormone levels following treatment with various enzyme inducers. Toxicol. Appl. Pharmacol., 111, 99-106.
24. Barter,R.A. and Klaassen,C.D. (1992) UDP-Glucuronyltransferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechanism. Toxicol. Appl. Pharmacol., 113, 36-42.